Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943306 · ClinicalTrials.gov registry record · Phase 3
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
A Phase 3 study, sponsored by Aegerion Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
NCT00943306 is a Phase 3 study that has completed, run by Aegerion Pharmaceuticals. The registered enrollment target is 19 participants.
The verdict
NCT00943306, a Phase 3 study, has completed, sponsored by Aegerion Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
Study Summary
This was a long term follow on study to assess the continued long term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia.
Interventions
- DRUG lomitapide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-10-29 |
| Est. Completion | 2014-12-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00943306
The ClinicalTrials.gov registry entry for NCT00943306 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aegerion Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lomitapide is the first listed.
NCT00943306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00943306 about?
NCT00943306 is a clinical study titled "Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia". This was a long term follow on study to assess the continued long term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia.
What is the current status of trial NCT00943306?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2009-10-29. Estimated completion is 2014-12-01.
What interventions are being tested in trial NCT00943306?
The interventions under investigation include: lomitapide (DRUG).
Who is sponsoring clinical trial NCT00943306?
This trial is sponsored by Aegerion Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.